CopyMark Law Group
4.9
Drawing for CARDIOXPRESS

USPTO serial 85853192

CARDIOXPRESS

Reviewed by CopyMark Law Group

Reg. 4554285Status 710
Filing date
Status date
Registration date
Jun 24, 2014
Examiner
HAYES, GINA CLARK
Law office
TMEG LAW OFFICE 103

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CARDIOXPRESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
009Apparatus for recording and transmitting the activity of cell cultures to note the field potential of cells; Bioreactor for cell culturing; Cell culture apparatus for laboratory use, namely, cardiac cells; Computer software platforms for Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Data compression software; Data processing apparatus; Electrical equipment for the genetic modification of cells for research purposes; Electronic apparatus for electropysiological measurement and testing of cells; Electronic communications systems comprised of computer hardware and software for the transmission of data between two points, namely, for retrieving signals from cardiomyocytes cells living in a multi-electrode arrays and connected to a specific action potential waveform analyzer; Electronic products for the manipulation of the frequency, time, and amplitude characteristics of audio signals, namely, audio processors; Instruments for detecting and measuring two-dimensional distribution of force and pressure; Laboratory apparatus, namely, centrifuges; Laboratory devices for detecting genetic sequences; Laboratory furniture; Laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; Medical imaging apparatus for small animals, in a research laboratory environment; Medical imaging software that records, monitors and analyzes data using a catheter based ultrasound imaging probe; Medical research equipment, namely, computers and multi-electrode array and plates having cardiomyocytes cells living inside all sold together as a unit for use in high resolution, high sensitivity tomographic image processing and imaging in the field of nuclear medicine; Medical software for Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications, namely, for drug discovery, drug safety evaluation using waveform analysis, mathematical simulation and study database; Pressure indicators; Pressure recorders; Scientific apparatus, namely, cellular mixed ester membranes for use in the science and research industry; Signal processors; Tool measuring instrumentsSECTION 8 - CANCELLED—
042Application service provider featuring application programming interface (API) software for Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications for drug discovery, drug safety evaluation using waveform analysis, mathematical simulation and study database; Bacteriological research; Bacteriological research and testing; Biological research; Biomedical research services; Compiling data for research purposes in the field of medical science and medical consultancy; Computer hardware development; Computer programming and computer system analysis; Computer programming in the medical field; Computer programming services for Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Computer software development; Computer software development, computer programming and maintenance of computer software for Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Computer systems analysis; Conducting clinical trials for others; Conducting early evaluations in the field of new pharmaceuticals; Data automation and collection service using proprietary software to evaluate, analyze and collect service data; Developing computer software; Development and creation of computer programmes for data processing; Development of new technology for others in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Medical and scientific research in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Platform as a service (PAAS) featuring computer software platforms for Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Product development in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Product research and development; Research and development in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Research and development in the pharmaceutical and biotechnology fields; Research and development of computer software; Research and development of technology in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Scientific research and development; Scientific research for medical purposes in the field of Physiology, Pharmacology, Toxicology, Anesthesiology, Surgery, Bio-medical research, clinical or industrial applications; Scientific research in the field of genetics and genetic engineering; Scientific research services for others in the field of sensory perceptions; Server hostingSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2021C8..CANCELLED SEC. 8 (6-YR)—
Jun 24, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 22, 2019COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Apr 16, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 26, 2019ES7RTEAS SECTION 7 REQUEST RECEIVED—
Feb 7, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 24, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 8, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 8, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 19, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 3, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 24, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 3, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 3, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2014ALIEASSIGNED TO LIE—
Jan 24, 2014NREVNOTICE OF REVIVAL - E-MAILED—
Jan 24, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2014PETGPETITION TO REVIVE-GRANTED—
Jan 24, 2014PROATEAS PETITION TO REVIVE RECEIVED—
Jan 21, 2014MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 21, 2014ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 24, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 24, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 10, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2013DOCKASSIGNED TO EXAMINER—
Feb 27, 2013MPMKNOTICE OF PSEUDO MARK E-MAILED—
Feb 26, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 22, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance